ClinVar Miner

Submissions for variant NM_000277.3(PAH):c.809G>A (p.Arg270Lys)

gnomAD frequency: 0.00002  dbSNP: rs62514950
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen PAH Variant Curation Expert Panel RCV000153632 SCV001370805 pathogenic Phenylketonuria 2020-06-08 reviewed by expert panel curation The c.809G>A (p.Arg270Lys) variant in PAH has been reported in multiple individuals with PAH deficiency (BH4 deficiency excluded). (PMID: 21871829, 23856132). This variant has an extremely low allele frequency (MAF=0.00016) in gnomAD. This variant has 11% residual PAH activity (PMID: 27620137). This variant was detected with multiple pathogenic variants: IVS10nt-11G>A (2 patients), L348V, S349P, R158Q, E390G, D415N (PMID: 21871829); and IVS4+5G>T (PMID: 23856132). Computational prediction tools and conservation analysis support a deleterious effect. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_very-strong, PM2, PP4_Moderate, PP3, PS3_supporting.
Eurofins Ntd Llc (ga) RCV000089105 SCV000203180 pathogenic not provided 2014-01-15 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000153632 SCV000629217 pathogenic Phenylketonuria 2024-11-05 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 270 of the PAH protein (p.Arg270Lys). This variant is present in population databases (rs62514950, gnomAD 0.009%). This missense change has been observed in individual(s) with phenylketonuria and hyperphenylalaninemia (PMID: 12173030, 20082265, 20187763, 23500595, 23856132). ClinVar contains an entry for this variant (Variation ID: 102846). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PAH protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PAH function (PMID: 16545551, 17935162, 25453233, 27620137). For these reasons, this variant has been classified as Pathogenic.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000153632 SCV000696467 pathogenic Phenylketonuria 2017-07-05 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000089105 SCV001249179 pathogenic not provided 2019-02-01 criteria provided, single submitter clinical testing
GeneDx RCV000089105 SCV002568584 pathogenic not provided 2022-05-18 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 8528673, 11180595, 20082265, 20187763, 23856132, 29749107, 34828281, 17935162, 25750018, 27620137, 9598724, 7914195, 12173030, 16545551, 25453233, 23500595, 21871829, 26666653, 31355225, 32778825, 33465300)
Baylor Genetics RCV000153632 SCV004209703 pathogenic Phenylketonuria 2024-01-26 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000089105 SCV004222249 pathogenic not provided 2022-01-25 criteria provided, single submitter clinical testing The variant has been reported in multiple individuals largely affected with classic PKU when another severe disease-causing variant is present on the other allele (PMID: 20082265 (2010), 21871829 (2011), 23856132 (2013), 26666653 (2015), 33465300 (2021)). Functional studies have shown that this variant causes severely reduced activity ranging from 2.1 to 11% of the wild-type activity (PMID: 16545551 (2006), 27620137 (2016)). Based on the available information, this variant is classified as pathogenic.
DeBelle Laboratory for Biochemical Genetics, MUHC/MCH RESEARCH INSTITUTE RCV000089105 SCV000119712 not provided not provided no assertion provided not provided
Natera, Inc. RCV000153632 SCV002088644 pathogenic Phenylketonuria 2020-11-06 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.